Diclofenac epolamine
Arthrotec, Cambia, Cataflam, Diclofenac, Flector, Licart, Voltaren, Zipsor, Zorvolex (diclofenac epolamine) is a small molecule pharmaceutical. Diclofenac epolamine was first approved as Voltaren on 1988-07-28.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| diclofenac epolamine | NDA authorized generic | 2025-09-25 |
| flector | New Drug Application | 2024-11-28 |
| licart | New Drug Application | 2024-11-28 |
| pennsaid | New Drug Application | 2024-11-21 |
| zipsor | New Drug Application | 2025-09-03 |
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
Expiration | Code | ||
|---|---|---|---|
DICLOFENAC POTASSIUM, ZIPSOR, ASSERTIO | |||
| 2024-05-25 | NPP | ||
Patent Expiration
Patent | Expires | Flag | FDA Information |
|---|---|---|---|
| Diclofenac Epolamine, Licart, Ibsa Inst Bio | |||
| 11344520 | 2035-02-20 | U-3393 | |
| 11351133 | 2035-02-20 | U-3393 | |
| Diclofenac Sodium, Pennsaid, Horizon | |||
| 8546450 | 2030-08-09 | U-1435, U-1436 | |
| 8217078 | 2029-07-10 | U-1248, U-1477 | |
| 8618164 | 2029-07-10 | U-1477 | |
| 8741956 | 2029-07-10 | U-1435 | |
| 9370501 | 2029-07-10 | U-1614 | |
| 9375412 | 2029-07-10 | U-1614 | |
| 9415029 | 2029-07-10 | U-1614 | |
| 8252838 | 2028-04-21 | DP | U-1489 |
| 8563613 | 2027-10-17 | DP | U-1488 |
| 8871809 | 2027-10-17 | U-1614 | |
| 9066913 | 2027-10-17 | DP | U-1488 |
| 9101591 | 2027-10-17 | DP | U-1488 |
| 9132110 | 2027-10-17 | U-1488 | |
| 9168304 | 2027-10-17 | DP | |
| 9168305 | 2027-10-17 | U-1488 | |
| 9220784 | 2027-10-17 | U-1488 | |
| 9339551 | 2027-10-17 | U-1488 | |
| 9339552 | 2027-10-17 | DP | U-1488 |
| 9539335 | 2027-10-17 | U-1614 | |
| Diclofenac, Zorvolex, Zyla | |||
| 8679544 | 2030-04-23 | DP | |
| 8999387 | 2030-04-23 | U-55 | |
| 9017721 | 2030-04-23 | DP | |
| 9173854 | 2030-04-23 | DP | |
| 9180095 | 2030-04-23 | U-55 | |
| 9180096 | 2030-04-23 | DP | |
| 9186328 | 2030-04-23 | U-55 | |
| Diclofenac Potassium, Zipsor, Assertio | |||
| 7662858 | 2029-02-24 | U-1035 | |
| 7884095 | 2029-02-24 | U-1111 | |
| 7939518 | 2029-02-24 | U-980 | |
| 8110606 | 2029-02-24 | U-980 | |
| 8623920 | 2029-02-24 | U-1482 | |
| 9561200 | 2029-02-24 | U-1482 | |
| Diclofenac Sodium, Dyloject, Javelin Pharms Inc | |||
| 8946292 | 2027-03-22 | U-1659 | |
| Diclofenac Potassium, Cambia, Assertio | |||
| 7759394 | 2026-06-16 | DS, DP | U-436 |
| 8097651 | 2026-06-16 | DS, DP | U-436 |
| 8927604 | 2026-06-16 | U-436 | |
| 9827197 | 2026-06-16 | DP | |
ATC Codes
D: Dermatologicals
— D11: Other dermatological preparations in atc
— D11A: Other dermatological preparations in atc
— D11AX: Other dermatological preparations in atc
— D11AX18: Diclofenac
M: Musculo-skeletal system drugs
— M01: Antiinflammatory and antirheumatic products
— M01A: Antiinflammatory and antirheumatic products, non-steroids
— M01AB: Acetic acid derivatives and related substances
— M01AB05: Diclofenac
— M01AB55: Diclofenac, combinations
— M02: Topical products for joint and muscular pain
— M02A: Topical products for joint and muscular pain
— M02AA: Antiinflammatory preparations, non-steroids for topical use
— M02AA15: Diclofenac
S: Sensory organ drugs
— S01: Ophthalmologicals
— S01B: Antiinflammatory agents, ophthalmologic
— S01BC: Antiinflammatory agents, non-steroidal, ophthalmologic
— S01BC03: Diclofenac
— S01C: Antiinflammatory agents and antiinfectives in combination
— S01CC: Antiinflammatory agents, non-steroids and antiinfectives in combination
— S01CC01: Diclofenac and antiinfectives
HCPCS
No data
Clinical
Clinical Trials
557 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Knee osteoarthritis | D020370 | EFO_0004616 | M17 | — | — | 1 | — | — | 1 |
| Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | — | 1 | — | — | 1 |
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Diclofenac epolamine |
| INN | diclofenac |
| Description | Diclofenac is a monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position. It has a role as a non-narcotic analgesic, an antipyretic, an EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor, a xenobiotic, an environmental contaminant, a drug allergen and a non-steroidal anti-inflammatory drug. It is a secondary amino compound, an amino acid, a dichlorobenzene, an aromatic amine and a monocarboxylic acid. It is functionally related to a phenylacetic acid and a diphenylamine. It is a conjugate acid of a diclofenac(1-). |
| Classification | Small molecule |
| Drug class | anti-inflammatory agents (acetic acid derivatives) |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl.OCCN1CCCC1 |
Identifiers
| PDB | — |
| CAS-ID | 15307-86-5 |
| RxCUI | 3355 |
| ChEMBL ID | CHEMBL1201180 |
| ChEBI ID | 48296 |
| PubChem CID | 3033 |
| DrugBank | DB00586 |
| UNII ID | 144O8QL0L1 (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
Cambia – Assertio Therapeutics
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Cambia – Assertio Therapeutics
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Arthrotec – Pfizer
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Zipsor – Assertio Therapeutics
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Zipsor – Assertio Therapeutics
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Estimated US medical usage
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 356 documents
View more details
Safety
Black-box Warning
Black-box warning for: Diclofenac epolamine, Flector, Licart, Pennsaid, Zipsor
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
112,715 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use